|
1.
|
Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT. Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study. J Nerv Ment Dis. 2013 Apr; 201(4):266-73.
|
|
|
|
|
2.
|
Deligiannidis KM, Sikoglu EM, Shaffer SA, Frederick B, Svenson AE, Kopoyan A, Kosma CA, Rothschild AJ, Moore CM. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: A preliminary study. J Psychiatr Res. 2013 Mar 14.
|
|
|
|
|
3.
|
Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Mulsant BH, Rudorfer MV, Marino P. Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD ??. BMC Psychiatry. 2013; 13(1):38.
|
|
|
|
|
4.
|
Leadholm AK, Rothschild AJ, Nolen WA, Bech P, Munk-Jørgensen P, Ostergaard SD. The treatment of psychotic depression: Is there consensus among guidelines and psychiatrists? J Affect Disord. 2013 Feb 20; 145(2):214-20.
|
|
|
|
|
5.
|
Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV. Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol. 2012 Dec; 22(12):858-66.
|
|
|
|
|
6.
|
Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord. 2012 Aug; 14(5):515-26.
|
|
|
|
|
7.
|
Marsh WK, Brown AP, Rothschild AJ. Manic episode after total abdominal hysterectomy with bilateral salpingo-oophorectomy: case report. Menopause. 2012 Apr; 19(4):476-8.
|
|
|
|
|
8.
|
Weissman J, Flint A, Meyers B, Ghosh S, Mulsant B, Rothschild A, Whyte E. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Psychiatry Res. 2012 May 30; 197(3):221-6.
|
|
|
|
|
9.
|
Ostergaard SD, Rothschild AJ, Uggerby P, Munk-Jørgensen P, Bech P, Mors O. Considerations on the ICD-11 classification of psychotic depression. Psychother Psychosom. 2012; 81(3):135-44.
|
|
|
|
|
10.
|
Ostergaard SD, Rothschild AJ, Bertelsen A, Mors O. Rethinking the classification of mixed affective episodes in ICD-11. J Affect Disord. 2012 Apr; 138(1-2):170-2.
|
|
|
|
|
11.
|
Blumberger DM, Mulsant BH, Emeremni C, Houck P, Andreescu C, Mazumdar S, Whyte E, Rothschild AJ, Flint AJ, Meyers BS. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. J Psychiatr Res. 2011 Jul; 45(7):896-901.
|
|
|
|
|
12.
|
Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT. Relationships between multiple sclerosis and depression. J Neuropsychiatry Clin Neurosci. 2011; 23(2):198-200.
|
|
|
|
|
13.
|
Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH. Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. J Psychiatr Res. 2011 Jan; 45(1):96-103.
|
|
|
|
|
14.
|
Trivedi MH, Dunner DL, Kornstein SG, Thase ME, Zajecka JM, Rothschild AJ, Friedman ES, Shelton RC, Keller MB, Kocsis JH, Gelenberg A. Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. J Affect Disord. 2010 Nov; 126(3):420-9.
|
|
|
|
|
15.
|
Flint AJ, Peasley-Miklus C, Papademetriou E, Meyers BS, Mulsant BH, Rothschild AJ, Whyte EM. Effect of age on the frequency of anxiety disorders in major depression with psychotic features. Am J Geriatr Psychiatry. 2010 May; 18(5):404-12.
|
|
|
|
|
16.
|
Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M. Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry Res. 2010 May 15; 177(1-2):177-83.
|
|
|
|
|
17.
|
Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009 Aug; 66(8):838-47.
|
|
|
|
|
18.
|
Rothschild AJ, Dunlop BW, Dunner DL, Friedman ES, Gelenberg A, Holland P, Kocsis JH, Kornstein SG, Shelton R, Trivedi MH, Zajecka JM, Goldstein C, Thase ME, Pedersen R, Keller MB. Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study. Psychopharmacol Bull. 2009; 42(3):5-20.
|
|
|
|
|
19.
|
Glezer A, Byatt N, Cook R, Rothschild AJ. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic. J Affect Disord. 2009 Sep; 117(1-2):18-23.
|
|
|
|
|
20.
|
Schaffer A, Flint AJ, Smith E, Rothschild AJ, Mulsant BH, Szanto K, Peasley-Miklus C, Heo M, Papademetriou E, Meyers BS. Correlates of suicidality among patients with psychotic depression. Suicide Life Threat Behav. 2008 Aug; 38(4):403-14.
|
|
|
|
|
21.
|
Rothschild AJ, Winer J, Flint AJ, Mulsant BH, Whyte EM, Heo M, Fratoni S, Gabriele M, Kasapinovic S, Meyers BS. Missed diagnosis of psychotic depression at 4 academic medical centers. J Clin Psychiatry. 2008 Aug; 69(8):1293-6.
|
|
|
|
|
22.
|
Kamara TS, Whyte EM, Mulsant BH, Peasley-Miklus C, Rothschild AJ, Flint AJ, Heo M, Papademetriou E, Mathis ER, Meyers BS. Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features? J Affect Disord. 2009 Jan; 112(1-3):250-5.
|
|
|
|
|
23.
|
Rothschild AJ. The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity. Compr Psychiatry. 2008 Sep-Oct; 49(5):508-13.
|
|
|
|
|
24.
|
Smith E, Rothschild AJ, Heo M, Peasley-Miklus C, Caswell M, Papademetriou E, Flint AJ, Mulsant BH, Meyers BS. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol. 2008 May; 23(3):130-7.
|
|
|
|
|
25.
|
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry. 2007 Dec 15; 62(12):1371-9.
|
|
|
|
|
26.
|
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry. 2007 Aug; 68(8):1246-56.
|
|
|
|
|
27.
|
Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry. 2007 Jul; 68(7):1014-23.
|
|
|
|
|
28.
|
Andreescu C, Mulsant BH, Peasley-Miklus C, Rothschild AJ, Flint AJ, Heo M, Caswell M, Whyte EM, Meyers BS. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features. J Clin Psychiatry. 2007 Feb; 68(2):194-200.
|
|
|
|
|
29.
|
Sit D, Rothschild AJ, Creinin MD, Hanusa BH, Wisner KL. Psychiatric outcomes following medical and surgical abortion. Hum Reprod. 2007 Mar; 22(3):878-84.
|
|
|
|
|
30.
|
Meyers BS, English J, Gabriele M, Peasley-Miklus C, Heo M, Flint AJ, Mulsant BH, Rothschild AJ. A delusion assessment scale for psychotic major depression: Reliability, validity, and utility. Biol Psychiatry. 2006 Dec 15; 60(12):1336-42.
|
|
|
|
|
31.
|
Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, Tohen MF, Woolson S, Zipursky RB. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006 Sep; 86(1-3):234-43.
|
|
|
|
|
32.
|
Rothschild AJ. Placebo response in psychotic depression. J Clin Psychiatry. 2005 Dec; 66(12):1615; author reply 1615-6.
|
|
|
|
|
33.
|
Rothschild AJ. Conflict-of-interest charge. Am J Psychiatry. 2004 Sep; 161(9):1721-2; discussion 1722.
|
|
|
|
|
34.
|
Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol. 2004 Aug; 24(4):365-73.
|
|
|
|
|
35.
|
Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004 Feb; 29(2):385-92.
|
|
|
|
|
36.
|
Rothschild AJ. Challenges in the treatment of depression with psychotic features. Biol Psychiatry. 2003 Apr 15; 53(8):680-90.
|
|
|
|
|
37.
|
Rothschild AJ, Duval SE. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry. 2003 Apr; 64(4):390-6.
|
|
|
|
|
38.
|
Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry. 2002 Sep 1; 52(5):386-92.
|
|
|
|
|
39.
|
Shindul-Rothschild J, Rothschild AJ. Benzodiazepine response. Am J Nurs. 2001 Nov; 101(11):13-4.
|
|
|
|
|
40.
|
Schatzberg AF, Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry. 2000 Jul; 157(7):1095-100.
|
|
|
|
|
41.
|
Zarate CA, Rothschild A, Fletcher KE, Madrid A, Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry. 2000 Mar; 61(3):185-9.
|
|
|
|
|
42.
|
Rothschild AJ, Shindul-Rothschild , Viguera A, Murray M, Brewster S. Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients. J Clin Psychopharmacol. 2000 Feb; 20(1):7-11.
|
|
|
|
|
43.
|
Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther. 2000; 22 Suppl A:A42-57; discussion A58-61.
|
|
|
|
|
44.
|
Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry. 2000; 61 Suppl 11:28-36.
|
|
|
|
|
45.
|
Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry. 1999 Jun; 156(6):977-8.
|
|
|
|
|
46.
|
Rothschild AJ, Bates KS, Boehringer KL, Syed A. Olanzapine response in psychotic depression. J Clin Psychiatry. 1999 Feb; 60(2):116-8.
|
|
|
|
|
47.
|
Moore BE, Rothschild AJ. Treatment of antidepressant-induced sexual dysfunction. Hosp Pract (Minneap). 1999 Jan 15; 34(1):89-91, 95-6.
|
|
|
|
|
48.
|
Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 1998 Jun; 59(6):279-88.
|
|
|
|
|
49.
|
Schatzberg AF, Samson JA, Rothschild AJ, Bond TC, Regier DA. McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression. Br J Psychiatry Suppl. 1998; (34):29-34.
|
|
|
|
|
50.
|
Byrne S, Rothschild AJ. Psychiatrists' responses to failure of maintenance therapy with antidepressants. Psychiatr Serv. 1997 Jun; 48(6):835-7.
|
|
|
|
|
51.
|
Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1997 Apr 15; 41(8):837-43.
|
|
|
|
|
52.
|
Kim E, Naisbitt S, Hsueh YP, Rao A, Rothschild A, Craig AM, Sheng M. GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol. 1997 Feb 10; 136(3):669-78.
|
|
|
|
|
53.
|
Kim E, Cho KO, Rothschild A, Sheng M. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron. 1996 Jul; 17(1):103-13.
|
|
|
|
|
54.
|
Rothschild AJ. Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am. 1996 Jun; 19(2):237-52.
|
|
|
|
|
55.
|
Rothschild AJ. On psychotic major depression. Am J Psychiatry. 1996 Jun; 153(6):847-8.
|
|
|
|
|
56.
|
Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry. 1996; 57 Suppl 5:5-11.
|
|
|
|
|
57.
|
Kim E, Niethammer M, Rothschild A, Jan YN, Sheng M. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature. 1995 Nov 2; 378(6552):85-8.
|
|
|
|
|
58.
|
Rothschild AJ. Delirium: an SSRI-benztropine adverse effect? J Clin Psychiatry. 1995 Nov; 56(11):537.
|
|
|
|
|
59.
|
Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995 Oct; 152(10):1514-6.
|
|
|
|
|
60.
|
Rothschild AJ. Advances in the management of depression: implications for the obstetrician/gynecologist. Am J Obstet Gynecol. 1995 Aug; 173(2):659-66.
|
|
|
|
|
61.
|
Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry. 1993 Sep 15; 34(6):392-400.
|
|
|
|
|
62.
|
Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry. 1993 Sep; 54(9):338-42.
|
|
|
|
|
63.
|
Rothschild AJ, Bessette MP, Carter-Campbell J, Murray M. Triazolam and disinhibition. Lancet. 1993 Jan 16; 341(8838):186.
|
|
|
|
|
64.
|
Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry. 1992 Dec; 53 Suppl:69-79.
|
|
|
|
|
65.
|
Schatzberg AF, Rothschild AJ. Serotonin activity in psychotic (delusional) major depression. J Clin Psychiatry. 1992 Oct; 53 Suppl:52-5.
|
|
|
|
|
66.
|
Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 1992 Jun; 149(6):733-45.
|
|
|
|
|
67.
|
Hudson JI, Lipinski JF, Keck PE, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ. Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry. 1992 May; 49(5):378-83.
|
|
|
|
|
68.
|
Rothschild AJ, Schatzberg AF. Theoretical basis for response to steroid suppression in major depression. J Clin Psychopharmacol. 1992 Apr; 12(2):142-4.
|
|
|
|
|
69.
|
Rothschild AJ, Locke CA. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry. 1991 Dec; 52(12):491-3.
|
|
|
|
|
70.
|
Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ. Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. J Clin Psychiatry. 1991 Jun; 52(6):250-4.
|
|
|
|
|
71.
|
Schatzberg AF, Samson JA, Rothschild AJ, Luciana MM, Bruno RF, Bond TC. Depression secondary to anxiety: findings from the McLean Hospital Depression Research Facility. Psychiatr Clin North Am. 1990 Dec; 13(4):633-49.
|
|
|
|
|
72.
|
Rothschild AJ, Benes F, Hebben N, Woods B, Luciana M, Bakanas E, Samson JA, Schatzberg AF. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry. 1989 Oct; 26(6):565-75.
|
|
|
|
|
73.
|
Frishman WH, Garofalo JL, Rothschild A, Rothschild M, Greenberg SM, Soberman J. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am J Cardiol. 1989 Sep 19; 64(11):65F-69F.
|
|
|
|
|
74.
|
Schatzberg AF, Rothschild AJ. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann N Y Acad Sci. 1988; 537:462-71.
|
|
|
|
|
75.
|
Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Res. 1987 Feb; 20(2):155-64.
|
|
|
|
|
76.
|
Rothschild AJ, Schatzberg AF, Langlais PJ, Lerbinger JE, Miller MM, Cole JO. Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures. Psychiatry Res. 1987 Feb; 20(2):143-53.
|
|
|
|
|
77.
|
Bond TC, Rothschild AJ, Lerbinger J, Schatzberg AF. Delusional depression, family history, and DST response: a pilot study. Biol Psychiatry. 1986 Nov; 21(13):1239-46.
|
|
|
|
|
78.
|
Rothschild AJ. Mania after withdrawal of isocarboxazid. J Clin Psychopharmacol. 1985 Dec; 5(6):340-2.
|
|
|
|
|
79.
|
Rothschild AJ, Schatzberg AF. Postdexamethasone cortisol levels and subgroups of affective illness. Arch Gen Psychiatry. 1985 Jul; 42(7):739.
|
|
|
|
|
80.
|
Rothschild AJ, Langlais PJ, Schatzberg AF, Miller MM, Saloman MS, Lerbinger JE, Cole JO, Bird ED. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 1985 Jul 1; 36(26):2491-501.
|
|
|
|
|
81.
|
Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. Br J Psychiatry. 1985 Jun; 146:633-7.
|
|
|
|
|
82.
|
Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res. 1985; 19(1):57-64.
|
|
|
|
|
83.
|
Rosenbaum AH, Schatzberg AF, MacLaughlin RA, Snyder K, Jiang NS, Ilstrup D, Rothschild AJ, Kliman B. The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age. Am J Psychiatry. 1984 Dec; 141(12):1550-5.
|
|
|
|
|
84.
|
Hudson JI, Hudson MS, Rothschild AJ, Vignati L, Schatzberg AF, Melby JC. Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatry. 1984 Nov; 41(11):1086-9.
|
|
|
|
|
85.
|
Schatzberg AF, Rothschild AJ, Bond TC, Cole JO. The DST in psychotic depression: diagnostic and pathophysiologic implications. Psychopharmacol Bull. 1984; 20(3):362-4.
|
|
|
|
|
86.
|
Langlais PJ, Rothschild AJ, Schatzberg AF, Cole JO, Bird ED. Dexamethasone elevates dopamine in human plasma and rat brain. Psychopharmacol Bull. 1984; 20(3):365-70.
|
|
|
|
|
87.
|
Rothschild AJ, Langlais PJ, Schatzberg AF, Walsh FX, Cole JO, Bird ED. Dexamethasone increases plasma free dopamine in man. J Psychiatr Res. 1984; 18(3):217-23.
|
|
|
|
|
88.
|
Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. Am J Psychiatry. 1983 Sep; 140(9):1231-3.
|
|
|
|
|
89.
|
Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO. The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry. 1983 Jan; 140(1):88-91.
|
|
|
|
|
90.
|
Rothschild AJ, Schatzberg AF, Rosenbaum AH, Stahl JB, Cole JO. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br J Psychiatry. 1982 Nov; 141:471-4.
|
|
|
|
|
91.
|
Rothschild AJ, Schatzberg AF. Fluctuating postdexamethasone cortisol levels in a patient with melancholia. Am J Psychiatry. 1982 Jan; 139(1):129-30.
|
|
|
|
